0001742947-21-000002.txt : 20210616 0001742947-21-000002.hdr.sgml : 20210616 20210615180110 ACCESSION NUMBER: 0001742947-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210616 DATE AS OF CHANGE: 20210615 EFFECTIVENESS DATE: 20210616 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tvardi Therapeutics, Inc. CENTRAL INDEX KEY: 0001742947 IRS NUMBER: 823784554 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-403053 FILM NUMBER: 211019904 BUSINESS ADDRESS: STREET 1: 2450 HOLCOMBE BOULEVARD STREET 2: SUITE X CITY: HOUSTON STATE: TX ZIP: 77021 BUSINESS PHONE: 832-413-1362 MAIL ADDRESS: STREET 1: 2450 HOLCOMBE BOULEVARD STREET 2: SUITE X CITY: HOUSTON STATE: TX ZIP: 77021 D 1 primary_doc.xml X0708 D LIVE 0001742947 Tvardi Therapeutics, Inc. 2450 Holcombe Boulevard Suite X HOUSTON TX TEXAS 77021 832-413-1362 DELAWARE None None Corporation true 2017 Imran Alibhai 2450 Holcombe Boulevard Suite X Houston TX TEXAS 77021 Executive Officer Director Wallace Hall 2450 Holcombe Boulevard Suite X Houston TX TEXAS 77021 Director Sujal Shah 2450 Holcombe Boulevard Suite X Houston TX TEXAS 77021 Director Michael Wyzga 2450 Holcombe Boulevard Suite X Houston TX TEXAS 77021 Director Jamie McNab 2450 Holcombe Boulevard Suite X Houston TX TEXAS 77021 Director Biotechnology Decline to Disclose 06b false 2021-06-03 false true false 0 75058256 72418254 2640002 false 32 0 0 0 false Tvardi Therapeutics, Inc. /s/ Imran Alibhai Imran Alibhai Chief Executive Officer 2021-06-15